Updated user guidelines will implement stricter device dosing limits and warn against extended high-intensity sessions to ensure safety in the use of red light therapy for myopia control. Regulatory approvals for the Eyerising device across several countries underscore its clinical benefits, but safety studies highlight potential risks that remain, especially for children. While the Mechanic's energy densities stay safely within known therapeutic ranges, experts urge caution regarding long-term effects and the wellness industry's marketing practices.
“Despite growing clinical interest in red light therapy for myopia control, which is currently only available outside the US...”
“The Eyerising International device has gained regulatory approval in several countries, including the UK, Japan, Vietnam, Australia, Colombia and Ecuador...”
“These findings, together with emerging clinical reports of retinal injury... highlight that safety validation has not kept pace with adoption. Until independent long-term safety data are available, caution is warranted, especially in children.”
“Red light therapy has legitimate biological potential, but the consumer market is a 'Wild West.'”
“Reassuringly, red light therapy appears safe when used appropriately and carefully.”
“In controlled clinical settings, it may offer modest benefits for specific uses like skin repair and hair regrowth.”
“Red light therapy is not a miracle cure-all, but it’s not a total scam either. The real danger comes from the wellness industry’s habit of turning 'some evidence' into 'life-changing transformation.'”
“Regulatory approval has been granted for the Eyerising Myopia Management Device (Eyerising International) in the UK, Japan, Vietnam, Australia, Columbia, and Ecuador.”
“These findings raise safety concerns for red light therapy devices. The EyeRising, Sky-n1202, and Future Vision devices produce a highly coherent laser beam, with EyeRising and Sky-n1202 surpassing safe viewing in shorter durations than the 180-second treatment period.”
Title not available for this citation.
“RLRL therapy has emerged as a promising therapeutic approach for addressing myopia anisometropia.”
Title not available for this citation.
“Notably, eyes with greater degrees of myopia exhibit more pronounced benefits, including AL shortening and reversal of SER progression.”
Title not available for this citation.
“Cycloplegic spherical equivalence refraction (SER) of more myopic eyes changed from -4.47 ± 2.37D to -4.40 ± 2.37D (p = 0.005).”
